PRECISIONBIOLOGICS
Menu
↗
Clinic operations

Lot release and quarantine, explained for clinic buyers

How suppliers describe quarantine-until-release and how clinics should mirror quarantine in receiving.

Reviewed 2026-10-27

Supplier-side quarantine

Many suppliers describe holding product until sterility and internal release criteria clear. Ask what released means in their paperwork.

Request whether you will receive evidence of release with each shipment or on demand.

Clinic-side quarantine

Even after supplier release, clinics often quarantine until identity, condition, and document checks finish.

Do not equate courier delivery with inventory release.

Open documentation items

Missing COA pages or unclear expiration dating keep a lot in clinic quarantine. Document the hold reason.

Do not infer missing fields from a previous lot of a different SKU.

Operational checklist for lot release quarantine biologics

Before ordering under the topic lot release quarantine biologics, confirm storage class, receiving owner, and which documents will be required at release.

Close open items in writing. Do not infer missing COA fields from a different lot or SKU.

FAQ

Frequently asked questions

Who should receive shipments?+

A trained receiving designee named in the SOP.

Can we skip documentation if a physician is waiting?+

No. Identity and condition checks come first.

Do all SKUs share one SOP?+

Use parallel SOPs when storage class or labeling differs.

Does this page determine how we may use products discussed under lot release quarantine biologics?+

No. Intended use remains with the ordering physician and clinic counsel.

Sources

  1. FDA: Minimal Manipulation and Homologous Use guidance ↗FDA
  2. 21 CFR Part 1271 ↗eCFR